IRBS Financial Statements From 2010 to 2026
| IRBSDelisted Stock | USD 0.0001 0.00 0.00% |
Check IR Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IR Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . IRBS financial statements analysis is a perfect complement when working with IR Biosciences Valuation or Volatility modules.
IRBS |
IR Biosciences Holdings Company Shares Outstanding Analysis
IR Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current IR Biosciences Shares Outstanding | 17.08 M |
Most of IR Biosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IR Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, IR Biosciences Holdings has 17.08 M of shares currently outstending. This is 87.48% lower than that of the Biotechnology sector and 39.54% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.01% higher than that of the company.
IR Biosciences Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IR Biosciences's current stock value. Our valuation model uses many indicators to compare IR Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IR Biosciences competition to find correlations between indicators driving IR Biosciences's intrinsic value. More Info.IR Biosciences Holdings is currently regarded as number one stock in return on asset category among its peers. It also is considered the number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value IR Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About IR Biosciences Financial Statements
IR Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although IR Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IR Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IR Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona. Ir Biosciences operates under Research Services classification in the United States and is traded on OTC Exchange. It employs 4 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in IRBS Stock
If you are still planning to invest in IR Biosciences Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IR Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |